Identification of the peptide derived from S1 domain that inhibits type I and type II feline infectious peritonitis virus infection
- 1 June 2015
- journal article
- research article
- Published by Elsevier in Virus Research
- Vol. 204, 13-20
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 51 references indexed in Scilit:
- Potent inhibition of feline coronaviruses with peptidyl compounds targeting coronavirus 3C-like proteaseAntiviral Research, 2013
- Structural Bases of Coronavirus Attachment to Host Aminopeptidase N and Its Inhibition by Neutralizing AntibodiesPLOS Pathogens, 2012
- Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptideBlood, 2011
- Extending Half-life by Indirect Targeting of the Neonatal Fc Receptor (FcRn) Using a Minimal Albumin Binding DomainJournal of Biological Chemistry, 2011
- Treatment of cats with feline infectious peritonitisVeterinary Immunology and Immunopathology, 2008
- Reversible PEGylation of peptide YY3‐36 prolongs its inhibition of food intake in miceFEBS Letters, 2005
- The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core ComplexJournal of Virology, 2003
- Molecular cloning and sequence determination of the peplomer protein gene of feline infectious peritonitis virus type IArchives of Virology, 1995
- A study on the mechanism of antibody-dependent enhancement of feline infectious peritonitis virus infection in feline macrophages by monoclonal antibodiesArchives of Virology, 1991
- Characterization of monoclonal antibodies against feline infectious peritonitis virus type II and antigenic relationship between feline, porcine, and canine coronavirusesArchives of Virology, 1991